Perimeter Medical Imaging AI Reports Strong Q2 2026 Results, Launches Claire OCT+AI
Event summary
- Q2 2026 revenue at $503,000, up 31% sequentially from Q1 2026.
- Operating expenses down 28% year-over-year to $3.1 million.
- First two commercial placements of Claire device in May 2026.
- Intermountain Health becomes first U.S. health system to deploy Claire.
- Closed $7.5 million in final tranche of Life Offering and $6.0 million in Debenture Offering.
The big picture
Perimeter Medical Imaging AI is transitioning from its legacy S-Series OCT to the next-generation Claire OCT+AI device, marking a strategic shift towards AI-enabled medical imaging. The company's strong Q2 2026 results, including significant cost reductions and initial commercial success with Claire, position it to capitalize on the growing demand for advanced imaging tools in cancer surgery. The deployment of Claire by Intermountain Health underscores the potential for broader market adoption.
What we're watching
- Commercial Momentum
- How the pace of Claire device placements will affect revenue growth in the coming quarters.
- Operational Efficiency
- Whether Perimeter can sustain the 28% year-over-year reduction in operating expenses.
- Market Adoption
- The pace at which major health systems will adopt Claire for real-time margin assessment in breast-conserving surgeries.